HETEROCYCLIC ANALOGS OF PROSTAGLANDINES: IV.
669
4.59 s (2H, CH2 of cycle), 6.21 d.t (1H, CH2CH=CHPh,
3J 16.0, 6.5 Hz), 6.40 br.d (1H, CH2CH=CHPh, 3Jtrans
16.0 Hz), 7.18 br.t (1H, H4arom, 3J 7.5 Hz), 7.27 t (2H, H3 +
H5arom, 3J 7.5 Hz), 7.33 br.d (2H, H2+H6arom, 3J 7.5 Hz).
13C NMR spectrum (CDCl3), δ, ppm: 14.8 (CH3), 23.0
(CH2), 65.9 (CH2), 74.9 (CH2), 92.1 (C), 126.1 (2CH),
126.9 (2CH), 128.4 (2CH), 130.2 (CH), 137.5 (C), 181.6
(C), 195.7 (C). Found, %: C 73.84; H 6.65. [M]+ 244.
C15H16O3. Calculated, %: C 73.75; H 6.60.
cm–1: 1535 sh, 1570 br (max), 1590 sh, 1615 sh, 1660,
3080 br, 3320. 1H NMR spectrum (CDCl3), δ, ppm:
0.87 t (3H, CH3, 3J 7.0 Hz), 0.88 t (3H, CH3, 3J 7.0 Hz),
1.15 m (2H, CH2), 1.19–1.33 m (14H, 7CH2), 1.44
3
quintet [2H, C(O)NHCH2CH2, J 7.0 Hz], 1.54 quintet
(2H, NHCH2CH2, 3J 6.5 Hz), 3.25 q (2H, NHCH2, 3J 7.0
3
Hz), 3.32 q [2H, C(O)NHCH2, J 7.0 Hz], 3.47 s (2H,
CH2Ar), 4.41 s [2H, OCH2C(O)NH], 4.55 s (2H, CH2 of
cycle), 5.16 br (1H, NH), 6.64 br [1H, C(O)NH], 6.72 br.d
(1Harom, 3J 8.0 Hz), 6.81 br.s (1H, H2arom), 6.89 d (1Harom
,
4-(3-Phenylpropyl)-5-ethoxy-2,3-dihydrofuran-3-
3J 8.0 Hz), 7.22 t (1H, H5arom, J 8.0 Hz). 13C NMR
spectrum (CDCl3), δ, ppm: 14.1 (2CH3), 22.5 (CH2), 22.6
(CH2), 26.0 (CH2), 26.3 (CH2), 26.8 (CH2), 28.7 (CH2),
28.9 (CH2), 29.6 (CH2), 30.0 (CH2), 31.6 (CH2), 31.7
(CH2), 39.1 (CH2), 41.4 (CH2), 67.2 (CH2), 74.4 (CH2),
90.5 (C), 112.0 (CH), 115.0 (CH), 121.8 (CH), 129.9
(CH), 141.7 (C), 157.6 (C), 168.0 (C), 177.8 (C), 192.6
(C). Found, %: C 70.56; H 9.29. [M]+ 458. C27H42N2O4.
Calculated, %: C 70.71; H 9.23.
3
one (LX). Yield 95%. IR spectrum, cm–1: 1610 br (max),
1
1705. H NMR spectrum (CDCl3), δ, ppm: 1.42 t (3H,
OCH2CH3, 3J 7.0 Hz), 1.78 quintet (2H, CH2CH2CH2Ph,
3
3J 7.5 Hz), 2.15 t [2H, CH2(CH2)2Ph, J 7.5 Hz],
2.61 t (2H, CH2Ph, 3J 7.5 Hz), 4.42 q (2H, OCH2CH3,
3J 7.0 Hz), 4.52 s (2H, CH2 of cycle), 7.15–7.19 m
(3Harom), 7.24–7.27 m (2Harom). 13C NMR spectrum
(CDCl3), δ, ppm: 14.8 (CH3), 19.3 (CH2), 29.7 (CH2),
35.6 (CH2), 65.7 (CH2), 74.7 (CH2), 93.7 (C), 125.6 (CH),
128.2 (2CH), 128.4 (2CH), 142.4 (C), 181.6 (C), 196.3
(C). Found, %: C 73.27; H 7.47. [M]+ 246. C15H18O3.
Calculated, %: C 73.15; H 7.37.
9-Oxa-7-azaprostanoids LVIII, LXI, and LXII were
obtained by procedure from [1].
Methyl 6-[3-(4-butoxy-3-methoxybenzyl)-4-oxo-
4,5-dihydrofuran-2-ylamino]hexanoate (LVIII).
Yield 40%, mp 63–65°C (from ether). IR spectrum,
The reaction of 4-substituted 5-ethoxy-2,3-dihydro-
furan-3-ones XLI and XLII with heptylamine was
carried out by the procedure of the synthesis of 11-oxa-
13-azaprostanoids [1].
1
cm–1: 1530 br, 1575 br, 1615 sh, 1680, 1735. H NMR
spectrum (CDCl3), δ, ppm: 0.97 t (3H, CH3, 3J 7.5 Hz),
1.19 quintet [2H, NH(CH2)2CH2(CH2)2CO2Me,
3J 7.5 Hz], 1.43 quintet (2H, CH2CH2CO2Me, 3J 7.5 Hz),
N-Heptyl-2-{4-[(2-(heptylamino)-4-oxo-4,5-di-
hydrofuran-3-yl)methyl]phenoxy}acetamide (LV).
Yield 58%, mp 140–142°C (from ethyl acetate). IR
spectrum, cm–1: 1515 sh, 1535 sh, 1550 sh, 1580 br
3
1.48 sextet [2H, O(CH2)2CH2CH3, J 7.5 Hz], 1.56
3
quintet (2H, NHCH2CH2, J 7.5 Hz), 1.80 quintet (2H,
OCH2CH2CH2CH3, 3J 7.0 Hz), 2.27 t (2H, CH2CO2Me,
3J 7.5 Hz), 3.22 q (2H, NHCH2, 3J 6.5 Hz), 3.44 s (2H,
CH2Ar), 3.66 s (3H, CO2CH3), 3.82 s (3H, OCH3),
3.97 t [2H, OCH2(CH2)2CH3, 3J 6.5 Hz], 4.52 br.s (2H,
CH2 of cycle), 5.27 br (1H, NH), 6.72–6.78 m (3Harom).
13C NMR spectrum (CDCl3), δ, ppm: 13.9 (CH3), 19.2
(CH2), 24.2 (CH2), 25.7 (CH2), 25.8 (CH2), 29.6 (CH2),
31.2 (CH2), 33.6 (CH2), 40.9 (CH2), 51.6 (CH3), 56.0
(CH3), 68.8 (CH2), 74.2 (CH2), 91.2 (C), 112.1 (CH),
112.9 (CH), 120.0 (CH), 131.8 (C), 147.2 (C), 149.7 (C),
173.9 (C), 177.8 (C), 192.5 (C). Found, %: C 65.78; H 7.92.
[M]+ 419. C23H33NO6. Calculated, %: C 65.85; H 7.93.
1
(max), 1605 sh, 1655, 3065, 3290. H NMR spectrum
(CDCl3), δ, ppm: 0.87 t (3H, CH3, 3J 7.5 Hz), 0.88 t (3H,
CH3, 3J 7.5 Hz), 1.14–1.35 m (16H, 8CH2), 1.44 quintet
[2H, C(O)NHCH2CH2, 3J 7.5 Hz], 1.54 quintet (2H,
NHCH2CH2, 3J 7.0 Hz), 3.24 q (2H, NHCH2, 3J 6.5 Hz),
3.32 q [2H, C(O)NHCH2, 3J 7.0 Hz], 3.43 s (2H, CH2Ar),
4.33 s [2H, OCH2C(O)NH], 4.51 s (2H, CH2 of cycle),
5.42 br (1H, NH), 6.64 br [1H, C(O)NH], 6.79 d (2Harom
,
3J 8.5 Hz), 7.15 d (2Harom, 3J 8.5 Hz). 13C NMR spectrum
(CDCl3), δ, ppm: 14.0 (2CH3), 22.5 (CH2), 22.6 (CH2),
25.1 (CH2), 26.4 (CH2), 26.8 (CH2), 28.8 (CH2), 28.9
(CH2), 29.6 (CH2), 30.0 (CH2), 31.7 (2CH2), 39.1 (CH2),
41.4 (CH2), 67.5 (CH2), 74.3 (CH2), 90.8 (C), 114.8
(2CH), 129.4 (2CH), 133.2 (C), 155.8 (C), 168.1 (C),
177.9 (C), 192.6 (C). Found, %: C 70.67; H 9.25. [M]+
458. C27H42N2O4. Calculated, %: C 70.71; H 9.23.
(Ε)-Methyl 6-(4-oxo-3-cinnamyl-4,5-dihydrofuran
-
2-ylamino)hexanoate (LXI). Yield 49%. IR spectrum,
cm–1: 1500, 1535 sh, 1555 sh, 1580 br (max), 1650, 1680,
1735, 3030 br, 3220 br. 1H NMR spectrum (CDCl3), δ,
ppm: 1.27 quintet [2H, NH(CH2)2CH2(CH2)2––CO2Me,
3J 7.5 Hz], 1.55 m [4H, NHCH2CH2CH2CH2CH2–
CO2Me], 2.20 t (2H, CH2CO2Me, 3J 7.5 Hz), 3.07 d (2H,
N-Heptyl-2-{3-[(2-(heptylamino)-4-oxo-4,5-
dihydrofuran-3-yl)methyl]phenoxy}acetamide (LVI).
Yield 47%, mp 99–101°C (from ether). IR spectrum,
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 44 No. 5 2008